世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039828

DNAメチル化市場:規模、シェア、動向分析レポート、およびセグメント予測、2024〜2030

Grand View Research Inc.

DNA Methylation Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2024- 2030

発刊日 2024/10

言語英語

体裁PDF/100ページ

ライセンス/価格100ページ

0000039828

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

DNAメチル化の市場規模、シェア、動向分析レポート:技術別 (PCR、マイクロアレイ、シーケンシング)、用途別 (遺伝子治療、診断)、製品別、最終用途別、地域別、セグメント予測、2024-2030

DNAメチル化の市場規模と動向

世界のDNAメチル化市場の規模は2023年に14億7000万ドルと評価されました。2024年から2030年にかけて14.1%のCAGRで拡大すると予想されます。世界的ながん症例数の増加が主な推進要因です。たとえば、米国の国立がん研究所が発表したがん統計によると、新しいがん症例の割合は、年間100,000人の男性と女性あたり約440.5例です。

レポート詳細

目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. DNA Methylation Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. DNA Methylation Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. DNA Methylation Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. DNA Methylation Market: Technology Movement Analysis, USD Billion, 2023 & 2030
4.3. Polymerase Chain Reaction (PCR)
4.3.1. Polymerase Chain Reaction (PCR) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Microarray
4.4.1. Microarray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Sequencing
4.5.1. Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Others
4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. DNA Methylation Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. DNA Methylation Market: Product Movement Analysis, USD Billion, 2023 & 2030
5.3. Consumables
5.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Kits & Reagents
5.4.1. Kits & Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Enzymes
5.5.1. Enzymes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Instruments & Software
5.6.1. Instruments & Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. DNA Methylation Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. DNA Methylation Market: Application Movement Analysis, USD Billion, 2023 & 2030
6.3. Gene Therapy
6.3.1. Gene Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Clinical Research
6.4.1. Clinical Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Diagnostics
6.5.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Others Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. DNA Methylation Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. DNA Methylation Market: End Use Movement Analysis, USD Million, 2023 & 2030
7.3. Hospital & Diagnostic Laboratories
7.3.1. Hospital & Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Research & Academia
7.5.1. Research & Academia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. DNA Methylation Market: Regional Estimates & Trend Analysis
8.1. DNA Methylation Market Share, By Region, 2023 & 2030, USD Million
8.2. North America
8.2.1. North America DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. China
8.4.2.1. China DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. Japan
8.4.3.1. Japan DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. South Korea
8.4.5.1. South Korea DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. Australia
8.4.6.1. Australia DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. Saudi Arabia
8.6.2.1. Saudi Arabia DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. UAE
8.6.3.1. UAE DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. South Africa
8.6.4.1. South Africa DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait DNA Methylation Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. New England Biolabs
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Sysmex Corporation
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. Abcam Limited
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. F. Hoffmann-La Roche Ltd
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Diagenode Diagnostics S.A.
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Thermo-Fisher Scientific Inc.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Agilent Technologies Inc.
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Bio-Rad Laboratories, Inc.
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Exact Sciences Corporation
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. QIAGEN
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives
9.4.11. Active Motif, Inc.
9.4.11.1. Participant’s Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Benchmarking
9.4.11.4. Recent Developments/ Strategic Initiatives
9.4.12. Illumina Inc.
9.4.12.1. Participant’s Overview
9.4.12.2. Financial Performance
9.4.12.3. Product Benchmarking
9.4.12.4. Recent Developments/ Strategic Initiatives

この商品のレポートナンバー

0000039828

TOP